Analyst Ratings for Rexnord Corp. (RXN)

Updated: 2017-07-27

Rexnord Corp. (NYSE:RXN) was awarded an average rating of Overweight from investment analysts following the stock. About 30 days ago, RXN was issued an average rating of Overweight.

Of the 9 analysts covering the stock, 5 gave it a buy rating, 1 issued an overweight rating, 1 issued a hold rating, 1 issued an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Investment analysts gave a few price targets for RXN. The maximum price target given was 27, implying a possible profit of 15.88 percent. The most pessimistic analyst gave a price target of 18, implying a possible loss of -22.75 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates downwards for this quarter, by about -3.7 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -7.14 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -1.17 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -4.89 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 1 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 1 analysts made negative revisions to their fiscal year's estimates.

The growth rate of RXN's earnings is estimated by analysts to be 88.49 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, but many choose to perform ratio comparisons with other companies in the industry. RXN has a PEG ratio of 0.41.

In the trailing 52-weeks, RXN hit 25.00 at the highest peak, while it's lowest trading point was 15.80. Today's price is 47.47 percent above the 52-week low, and below the high by 6.8 percent. RXN has a price/earnings ratio of 35.85. Investors typically compare the P/E ratio to a company's peers in the industry. The RXN value stock report compares RXN to some of its peers using value stock charts. The stock has a market capitalization of $2.48 billion. RXN's next earnings release will be on 0000-00-00, which is days away.